Anti-angiogenic therapy of proliferative diabetic retinopathy

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.2.3.395PMID 11336594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

  2004cited by this paper
• Intravitreal triamcinolone acetonide for exudative age related macular degeneration

  2003cited by this paper
• Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

  2001cited by this paper
• Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

  2000cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE‐RELATED MACULAR DEGENERATION

  2000cited by this paper
• Clinical strategy for the development of angiogenesis inhibitors.

  2000cited by this paper
• Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy.

  2000cited by this paper
• AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells.

  2000cited by this paper
• Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases

  2000influential reference
• Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

  2000cited by this paper
• Pharmacokinetics, Pharmacodynamics, and Safety of Microencapsulated Octreotide Acetate in Healthy Subjects

  2000cited by this paper
• Glycoxidation and lipoxidation in atherogenesis.

  2000cited by this paper
• Matrix metalloproteinases: biologic activity and clinical implications.

  2000cited by this paper
• Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine

  2000cited by this paper
• Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

  2000cited by this paper
• ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.

  2000cited by this paper
• Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections.

  2000cited by this paper
• VEGF is major stimulator in model of choroidal neovascularization.

  2000cited by this paper
• The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.

  2000cited by this paper
• Retinal and choroidal neovascularization

  2000cited by this paper
• Corticosteroids as an Antiangiogenic Agent for Histoplasmosis-Related Subfoveal Choroidal Neovascularization

  1999cited by this paper
• Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.

  1999cited by this paper
• Barriers to compliance with screening guidelines for diabetic retinopathy.

  1999cited by this paper
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

  1999cited by this paper
• Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.

  1999cited by this paper
• ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy.

  1999cited by this paper
• Alterations in protein tyrosine kinase pathways following retinal vein occlusion in the rat.

  1999cited by this paper
• Dexamethasone Reduces Oxygen Induced Retinopathy in a Mouse Model

  1999cited by this paper
• VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

  1999cited by this paper
• Gelatinase B in proliferative vitreoretinal disorders.

  1998cited by this paper
• Vitrectomy for complications of diabetic retinopathy.

  1998cited by this paper
• Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.

  1998cited by this paper
• Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.

  1998cited by this paper
• Diabetic microangiopathy

  1998cited by this paper
• The U.K. Prospective Diabetes Study: A review

  1998cited by this paper
• Vitamin A Deficiency and Its Effects on the Eye

  1998cited by this paper
• Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531.

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.

  1998cited by this paper
• Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.

  1998cited by this paper
• Protein kinase C activation and the development of diabetic complications.

  1998cited by this paper
• Pharmacologic vitreolysis.

  1998cited by this paper
• Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.

  1997cited by this paper
• Salt Restriction Reduces Hyperfiltration, Renal Enlargement, and Albuminuria in Experimental Diabetes

  1997cited by this paper
• Diabetic microangiopathy

  1997cited by this paper
• Growth Factor Alterations in Advanced Diabetic Retinopathy: A Possible Role of Blood Retina Barrier Breakdown

  1997cited by this paper
• Essential role of growth hormone in ischemia-induced retinal neovascularization.

  1997cited by this paper
• Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor

  1997cited by this paper
• Insulin-like growth factor-1 retinal microangiopathy in the pig eye.

  1997cited by this paper
• Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model.

  1996cited by this paper
• Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

  1996cited by this paper
• Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

  1996cited by this paper
• Intensive Insulin Therapy in Type II Diabetes: Rationale and Collaborative Clinical Trial Results

  1996cited by this paper
• Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.

  1996cited by this paper
• Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization

  1996cited by this paper
• (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.

  1996cited by this paper
• Definition of two angiogenic pathways by distinct alpha v integrins.

  1995cited by this paper
• Hypoxic regulation of vascular endothelial growth factor in retinal cells.

  1995cited by this paper
• Definition of Two Angiogenic Pathways by Distinct αv Integrins

  1995cited by this paper
• The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.

  1995cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

  1994cited by this paper
• Diseases of the retina.

  1994cited by this paper
• How effective are treatments for diabetic retinopathy?

  1993cited by this paper
• Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation.

  1993cited by this paper
• Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.

  1992cited by this paper
• Involvement of protein kinase-C in the mitogenic effect of insulin-like growth factor-I on rat astrocytes.

  1992cited by this paper
• Influence of pericytes on capillary endothelial cell growth.

  1989cited by this paper
• Progression of Incipient Diabetic Retinopathy During Good Glycemic Control

  1987cited by this paper
• Ten years after the Diabetic Retinopathy Study.

  1987cited by this paper
• Angiostatic steroids. Method of discovery and mechanism of action.

  1987cited by this paper
• Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.

  1986cited by this paper
• A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.

  1986cited by this paper
• Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.

  1985cited by this paper
• The management of diabetic eye disease.

  1985cited by this paper
• ANGIOGENESIS: INITIATION AND CONTROL *

  1982cited by this paper
• Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.

  1978cited by this paper
• A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes.

  1978cited by this paper
• Vitrectomy for Complications of Diabetic Retinopathy

  1978cited by this paper
• Florid Diabetic Retinopathy and its Response to Treatment by Photocoagulation or Pituitary Ablation

  1976cited by this paper
• Diseases of the Retina

  1948cited by this paper

• Deglycosylation of VEGF Produced in Pichia pastoris Reduces its in Vitro Binding and Angiogenic Effect

  2025cites this paper
• Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform

  2020cites this paper
• Mapping Tyrosine Kinase Receptor Dimerization to Receptor Expression and Ligand Affinities

  2019cites this paper
• Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.

  2019cites this paper
• Soluble Production of Human Recombinant VEGF-A121 by Using SUMO Fusion Technology in Escherichia coli

  2018cites this paper
• Role of IGF-1 signaling in the pathology of diabetic retinopathy

  2015cites this paper
• [Role of angiostatins in diabetic complications].

  2015cites this paper
• Anti-glycation and anti-angiogenic activities of 5'-methoxybiphenyl-3,4,3'-triol, a novel phytochemical component of Osteomeles schwerinae.

  2015cites this paper
• The role of angiostatins in diabetic complications

  2014cites this paper
• Vibration perception threshold for sight‐threatening retinopathy screening in type 2 diabetic outpatients

  2013cites this paper
• CorrigendumCorrigendum to “Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: Analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog” [Biochem. Pharmacol. 77 (2009) 1011–1020]

  2010cites this paper
• Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose.

  2010cites this paper
• Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog.

  2009cites this paper
• Expression of integrins in human proliferative diabetic retinopathy membranes.

  2008cites this paper
• Increased Osteopontin Levels in the Vitreous of Patients with Diabetic Retinopathy

  2007cites this paper
• Multifocal Electroretinography (mfERG) in Insulin Dependent Diabetics with and without Clinically Apparent Retinopathy

  2005cites this paper
• Angiostatin and anti-angiogenic therapy in human disease.

  2004cites this paper
• Gene therapy for proliferative ocular diseases

  2004cites this paper
• Retinal Delivery of Celecoxib Is Several-Fold Higher Following Subconjunctival Administration Compared to Systemic Administration

  2004cites this paper
• Laser literature watch.

  2003cites this paper
• Therapies directed at vascular endothelial growth factor

  2002cites this paper
• Untersuchung der prognostischen Relevanz der VEGF- und MMP-9-Spiegel beim nicht-kleinzelligen Bronchialkarzinom an 118 Patienten

  2001cites this paper